Sommadossi Jean-Pierre

CIK 00012969954 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001296995

Recent Transactions

34 trades

Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+173,467→ 290,024 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31+99,518→ 99,518 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+99,517→ 389,541 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31$3.06/sh−88,601→ 300,940 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31−173,467→ 173,466 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-01-31+440,000→ 440,000 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-09-19$4.00/sh−1,841→ 5,866,025 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-09-18$4.03/sh−22,187→ 5,867,866 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-09-17$4.05/sh−33,941→ 5,890,053 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-06-05$4.00/sh−1,006→ 5,923,994 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-02-01$3.85/sh−56,910→ 116,557 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-01-31+448,000→ 448,000 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-01-31−173,467→ 346,933 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-01-31+173,467→ 173,467 total
Disposition to Issuer
ABG Acquisition Corp. I
Class B ordinary shares
2023-03-01−32,500→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-01-31+520,400→ 520,400 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-01-31+728,600→ 728,600 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-01-31+378,033→ 378,033 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2021-06-28+26,000→ 26,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-01-29+640,000→ 640,000 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Series A Convertible Preferred Stock
2020-11-03−750,000→ 0 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2020-11-03+750,000→ 5,925,000 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2020-06-24+8,896→ 8,896 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2019-06-25+8,896→ 8,896 total
Conversion
Kezar Life Sciences, Inc.$KZR
Series A Convertible Perferred Stock
2018-06-25−52,581→ 0 total
Conversion
Kezar Life Sciences, Inc.$KZR
Common Stock
2018-06-25+52,581→ 143,182 total
Conversion
Kezar Life Sciences, Inc.$KZR
Common Stock
2018-06-25+35,258→ 178,440 total
Conversion
Kezar Life Sciences, Inc.$KZR
Series B Convertible Perferred Stock
2018-06-25−35,258→ 0 total
Award
IDENIX PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2010-02-10+400,000→ 400,000 total
Award
IDENIX PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2009-02-13+400,000→ 400,000 total
Award
IDENIX PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2007-06-01+150,000→ 150,000 total
Award
IDENIX PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2005-02-28+150,000→ 150,000 total
Exercise/Conversion
IDENIX PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2004-08-26−43,750→ 56,250 total
Exercise/Conversion
IDENIX PHARMACEUTICALS INC
Common Stock
2004-08-26$8.50/sh+43,750→ 2,007,614 total

Companies

Recent Filings

Address

C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov